Display options
Share it on

J Geriatr Cardiol. 2012 Sep;9(3):305-17. doi: 10.3724/SP.J.1263.2012.02132.

Atherosclerosis: from biology to pharmacological treatment.

Journal of geriatric cardiology : JGC

Graziano Riccioni, Valeriana Sblendorio

Affiliations

  1. Cardiology Unit, San Camillo de Lellis Hospital, Manfredonia, Via Isonzo 71043 Manfredonia (FG), Italy.

PMID: 23097661 PMCID: PMC3470030 DOI: 10.3724/SP.J.1263.2012.02132

Abstract

A recent explosion in the amount of cardiovascular risk has swept across the globe. Primary prevention is the preferred method to lower cardiovascular risk. Lowering the prevalence of obesity is the most urgent matter, and is pleiotropic since it affects blood pressure, lipid profiles, glucose metabolism, inflammation, and atherothrombotic disease progression. Given the current obstacles, success of primary prevention remains uncertain. At the same time, the consequences of delay and inaction will inevitably be disastrous, and the sense of urgency mounts. Pathological and epidemiological data confirm that atherosclerosis begins in early childhood, and advances seamlessly and inexorably throughout life. Risk factors in childhood are similar to those in adults, and track between stages of life. When indicated, aggressive treatment should begin at the earliest indication, and be continued for many years. For those patients at intermediate risk according to global risk scores, C-reactive protein, coronary artery calcium, and carotid intima-media thickness are available for further stratification. Using statins for primary prevention is recommended by guidelines, is prevalent, but remains under prescribed. Statin drugs are unrivaled, evidence-based, major weapons to lower cardiovascular risk. Even when low density lipoprotein cholesterol targets are attained, over half of patients continue to have disease progression and clinical events. Though clinical evidence is incomplete, altering or raising the blood high density lipoprotein cholesterol level continues to be pursued. The aim of this review is to point out the attention of key aspects of vulnerable plaques regarding their pathogenesis and treatment.

Keywords: Atherosclerosis; Carotid intima-media thickness; Coronary heart disease; Hypertension; Metabolic syndrome; Statins

References

  1. Curr Cardiovasc Imaging Rep. 2012 Feb;5(1):60-68 - PubMed
  2. J Am Coll Cardiol. 1985 Jun;5(6):1428-37 - PubMed
  3. Am Heart J. 2001 Feb;141(2):211-7 - PubMed
  4. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1858-63 - PubMed
  5. Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):839-45 - PubMed
  6. J Leukoc Biol. 1998 Mar;63(3):373-9 - PubMed
  7. Nat Med. 2009 Jan;15(1):97-103 - PubMed
  8. N Engl J Med. 2001 Aug 16;345(7):494-502 - PubMed
  9. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2054-61 - PubMed
  10. J Am Coll Cardiol. 2008 Apr 22;51(16):1539-42 - PubMed
  11. Blood. 2007 Jan 1;109(1):122-9 - PubMed
  12. Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):845-50 - PubMed
  13. Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2909-17 - PubMed
  14. Physiol Rev. 2006 Apr;86(2):515-81 - PubMed
  15. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1720-6 - PubMed
  16. Circulation. 1995 Aug 1;92(3):657-71 - PubMed
  17. Heart. 2000 Mar;83(3):361-6 - PubMed
  18. Hematology Am Soc Hematol Educ Program. 2011;2011:51-61 - PubMed
  19. Circ Cardiovasc Imaging. 2011 May;4(3):201-9 - PubMed
  20. J Pathol. 2009 May;218(1):7-29 - PubMed
  21. Circulation. 2001 Feb 13;103(6):806-12 - PubMed
  22. N Engl J Med. 2010 Jul 8;363(2):166-76 - PubMed
  23. Circulation. 2002 Apr 23;105(16):2000-4 - PubMed
  24. Lab Invest. 1997 Nov;77(5):533-9 - PubMed
  25. Nat Rev Cardiol. 2009 Nov;6(11):669 - PubMed
  26. N Engl J Med. 2009 Sep 10;361(11):1045-57 - PubMed
  27. Arterioscler Thromb Vasc Biol. 2005 Jan;25(1):18-28 - PubMed
  28. Stroke. 2004 Oct;35(10):2253-7 - PubMed
  29. Atherosclerosis. 2007 Dec;195(2):e10-8 - PubMed
  30. Physiol Rev. 2005 Jan;85(1):1-31 - PubMed
  31. Nat Rev Immunol. 2006 Jul;6(7):508-19 - PubMed
  32. Prev Cardiol. 2010 Fall;13(4):160-5 - PubMed
  33. Nat Med. 2003 Jan;9(1):61-7 - PubMed
  34. N Engl J Med. 1990 Nov 8;323(19):1289-98 - PubMed
  35. J Am Coll Cardiol. 2007 Mar 27;49(12):1272-8 - PubMed
  36. N Engl J Med. 2008 Nov 20;359(21):2195-207 - PubMed
  37. Cardiovasc Res. 2008 Apr 1;78(1):175-84 - PubMed
  38. Circulation. 2000 Apr 25;101(16):1899-906 - PubMed
  39. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):612-9 - PubMed
  40. Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1885-94 - PubMed
  41. Circulation. 2010 Jun 8;121(22):2388-97 - PubMed
  42. J Am Coll Cardiol. 2005 Oct 4;46(7):1209-18 - PubMed
  43. Arterioscler Thromb. 1994 May;14(5):746-52 - PubMed
  44. Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1635-40 - PubMed
  45. J Behav Med. 1987 Oct;10(5):481-500 - PubMed
  46. N Engl J Med. 2009 Nov 26;361(22):2113-22 - PubMed
  47. Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1220-7 - PubMed
  48. J Am Coll Cardiol. 2010 Jun 8;55(23):2527-35 - PubMed
  49. Semin Thromb Hemost. 2005 Apr;31(2):234-46 - PubMed
  50. Drug Des Devel Ther. 2010 Dec 09;4:383-413 - PubMed
  51. Thromb Haemost. 2002 Jul;88(1):41-7 - PubMed
  52. Nat Med. 2002 Nov;8(11):1218-26 - PubMed
  53. Arch Intern Med. 2011 Feb 28;171(4):286-91 - PubMed
  54. Health Aff (Millwood). 2010 Sep;29(9):1656-60 - PubMed
  55. J Am Coll Cardiol. 2005 Jun 21;45(12):1946-53 - PubMed
  56. Circulation. 2001 Jun 26;103(25):3047-50 - PubMed
  57. Circulation. 2011 Mar 1;123(8):933-44 - PubMed
  58. Nat Med. 2008 Oct;14(10):1059-66 - PubMed
  59. Radiology. 2007 Jul;244(1):64-77 - PubMed
  60. J Am Coll Cardiol. 2009 Jun 30;54(1):49-57 - PubMed
  61. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12752-7 - PubMed
  62. Circulation. 1993 Jun;87(6):1781-91 - PubMed
  63. J Clin Psychol. 2011 Feb;67(2):143-54 - PubMed
  64. Circulation. 2006 Apr 4;113(13):1708-14 - PubMed
  65. Thromb Haemost. 2008 Feb;99(2):286-9 - PubMed
  66. J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103 - PubMed
  67. J Am Coll Cardiol. 2009 Apr 28;53(17):1517-27 - PubMed
  68. Risk Manag Healthc Policy. 2010;3:49-60 - PubMed
  69. Circulation. 2001 Feb 20;103(7):926-33 - PubMed
  70. Circulation. 2002 Aug 6;106(6):653-8 - PubMed
  71. Nature. 2008 Feb 21;451(7181):953-7 - PubMed
  72. N Engl J Med. 2007 Nov 15;357(20):2001-15 - PubMed
  73. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5252-6 - PubMed
  74. Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):120-7 - PubMed
  75. Lancet. 1999 Aug 7;354(9177):447-55 - PubMed
  76. Lancet. 1992 Mar 7;339(8793):563-9 - PubMed
  77. Lancet. 2010 Jan 9;375(9709):132-40 - PubMed
  78. J Exp Med. 2002 Jan 7;195(1):15-21 - PubMed
  79. Am J Cardiol. 1990 Dec 1;66(19):1368-72 - PubMed
  80. J Am Coll Cardiol. 1998 Mar 1;31(3):547-51 - PubMed
  81. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):373-9 - PubMed
  82. J Clin Invest. 2003 Mar;111(6):897-906 - PubMed
  83. Circ Res. 2007 Jan 5;100(1):27-40 - PubMed
  84. Front Biosci. 2008 Jan 01;13:453-61 - PubMed
  85. Eur J Epidemiol. 2004;19(12):1127-33 - PubMed
  86. Cardiovasc Res. 2003 Oct 1;59(4):971-9 - PubMed
  87. J Am Coll Cardiol. 2005 Sep 20;46(6):937-54 - PubMed
  88. Nat Clin Pract Cardiovasc Med. 2007 Sep;4(9):491-502 - PubMed
  89. Acta Cardiol. 2004 Apr;59(2):119-25 - PubMed
  90. Nature. 2002 Dec 19-26;420(6917):868-74 - PubMed
  91. J Am Board Fam Med. 2006 Jan-Feb;19(1):46-53 - PubMed
  92. Circulation. 2007 Oct 23;116(17):1931-41 - PubMed
  93. Curr Cardiol Rev. 2011 Feb;7(1):22-7 - PubMed
  94. J Am Coll Cardiol. 1994 Feb;23(2):452-8 - PubMed
  95. Circulation. 2000 Mar 7;101(9):948-54 - PubMed
  96. N Engl J Med. 2005 Apr 21;352(16):1685-95 - PubMed
  97. Circulation. 2008 Sep 9;118(11):1172-82 - PubMed
  98. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):340-6 - PubMed
  99. J Thromb Haemost. 2010 Jun;8(6):1394-402 - PubMed
  100. N Engl J Med. 2000 Jan 20;342(3):145-53 - PubMed
  101. Prev Med. 2004 Feb;38(2):129-36 - PubMed
  102. Curr Opin Lipidol. 2009 Feb;20(1):24-9 - PubMed
  103. N Engl J Med. 2008 Apr 10;358(15):1547-59 - PubMed
  104. Heart. 2010 Nov;96(21):1716-22 - PubMed
  105. Am J Cardiol. 2005 Sep 5;96(5A):61F-68F - PubMed
  106. JAMA. 1998 Apr 22-29;279(16):1288-92 - PubMed
  107. Lancet. 2009 Jun 20;373(9681):2125-35 - PubMed
  108. Circulation. 2001 Jul 24;104(4):387-92 - PubMed
  109. FASEB J. 2006 Oct;20(12):2159-61 - PubMed
  110. Curr Pharm Des. 2007;13(10):1039-52 - PubMed
  111. Clin Chem. 2010 Apr;56(4):559-67 - PubMed
  112. Semin Immunopathol. 2009 Jun;31(1):79-94 - PubMed
  113. Circulation. 2000 May 30;101(21):2450-3 - PubMed
  114. Circulation. 1999 Apr 6;99(13):1726-32 - PubMed
  115. Circulation. 2011 Feb 1;123(4):e18-e209 - PubMed
  116. Health Educ Q. 1984 Spring;11(1):1-47 - PubMed
  117. Expert Rev Cardiovasc Ther. 2007 May;5(3):371-4 - PubMed
  118. Curr Med Chem. 2009;16(14):1799-805 - PubMed
  119. Curr Opin Lipidol. 2009 Aug;20(4):321-6 - PubMed
  120. Am J Pathol. 2002 Feb;160(2):673-80 - PubMed
  121. J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C7-12 - PubMed
  122. Circulation. 2007 May 15;115(19):2516-25 - PubMed
  123. J Am Coll Cardiol. 2009 Nov 3;54(19):1787-94 - PubMed
  124. Circ Res. 2001 Nov 9;89(10):930-4 - PubMed
  125. Circulation. 2008 Mar 25;117(12):1594-602 - PubMed
  126. Ann Intern Med. 2007 Jul 3;147(1):10-8 - PubMed
  127. J Cardiovasc Pharmacol. 2001 Sep;38(3):395-405 - PubMed
  128. N Engl J Med. 2004 Apr 8;350(15):1495-504 - PubMed

Publication Types